Daniel F. Wyss

7.3k total citations · 1 hit paper
58 papers, 3.4k citations indexed

About

Daniel F. Wyss is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Daniel F. Wyss has authored 58 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 14 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Immunology. Recurrent topics in Daniel F. Wyss's work include Monoclonal and Polyclonal Antibodies Research (13 papers), Hepatitis C virus research (10 papers) and Protein Structure and Dynamics (9 papers). Daniel F. Wyss is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (13 papers), Hepatitis C virus research (10 papers) and Protein Structure and Dynamics (9 papers). Daniel F. Wyss collaborates with scholars based in United States, Switzerland and United Kingdom. Daniel F. Wyss's co-authors include Michael Leunig, Martín Beck, Javad Parvizi, Reinhold Ganz, Mark A. McCoy, Gerhard Wagner, James Bausch, Stephen K. Youngster, Alexandre Trifilieff and Ellis L. Reinherz and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Daniel F. Wyss

58 papers receiving 3.3k citations

Hit Papers

Anterior Femoroacetabular Impingement 2004 2026 2011 2018 2004 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel F. Wyss United States 31 1.6k 711 454 447 382 58 3.4k
Gÿorgý Kéri Hungary 41 3.5k 2.2× 314 0.4× 479 1.1× 349 0.8× 592 1.5× 162 6.1k
Linda K. Jolliffe United States 31 1.5k 1.0× 218 0.3× 959 2.1× 815 1.8× 282 0.7× 60 3.7k
Gary D. Glick United States 36 4.2k 2.7× 372 0.5× 1.6k 3.4× 376 0.8× 393 1.0× 98 6.0k
Nadya I. Tarasova United States 34 2.5k 1.6× 341 0.5× 562 1.2× 215 0.5× 252 0.7× 94 3.9k
Dianne L. Newton United States 35 3.1k 2.0× 139 0.2× 768 1.7× 357 0.8× 301 0.8× 87 4.6k
Bradley J. Backes United States 30 2.9k 1.9× 497 0.7× 450 1.0× 265 0.6× 1.3k 3.5× 45 5.0k
Brian C. Cunningham United States 33 4.4k 2.8× 360 0.5× 936 2.1× 1.5k 3.3× 285 0.7× 47 6.9k
José A. Halperin United States 38 2.1k 1.4× 359 0.5× 1.3k 2.9× 220 0.5× 622 1.6× 101 4.7k
Marc Goethals Belgium 34 1.9k 1.2× 471 0.7× 294 0.6× 155 0.3× 74 0.2× 105 4.5k
Daniel A. Bachovchin United States 34 4.1k 2.6× 296 0.4× 971 2.1× 155 0.3× 1.1k 2.9× 54 5.5k

Countries citing papers authored by Daniel F. Wyss

Since Specialization
Citations

This map shows the geographic impact of Daniel F. Wyss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel F. Wyss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel F. Wyss more than expected).

Fields of papers citing papers by Daniel F. Wyss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel F. Wyss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel F. Wyss. The network helps show where Daniel F. Wyss may publish in the future.

Co-authorship network of co-authors of Daniel F. Wyss

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel F. Wyss. A scholar is included among the top collaborators of Daniel F. Wyss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel F. Wyss. Daniel F. Wyss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sikorska, Justyna & Daniel F. Wyss. (2024). Recent developments in understanding RIG-I's activation and oligomerization. Science Progress. 107(3). 342235678–342235678. 1 indexed citations
2.
Sikorska, Justyna, Yan Hou, Tony Siu, et al.. (2023). Characterization of RNA driven structural changes in full length RIG-I leading to its agonism or antagonism. Nucleic Acids Research. 51(17). 9356–9368. 6 indexed citations
3.
Schnell, Christian, Daniel F. Wyss, Jiaping Gao, et al.. (2021). Abstract P137: SGLT2 inhibition improves BYL719-induced hyperglycemia and hyperinsulinemia in rat pre-clinical models. Molecular Cancer Therapeutics. 20(12_Supplement). P137–P137. 2 indexed citations
4.
Kim, Hai‐Young & Daniel F. Wyss. (2014). NMR Screening in Fragment-Based Drug Design: A Practical Guide. Methods in molecular biology. 1263. 197–208. 7 indexed citations
7.
Wyss, Daniel F., et al.. (2008). Comparison of Cigarette Smoke-Induced Acute Inflammation in Multiple Strains of Mice and the Effect of a Matrix Metalloproteinase Inhibitor on These Responses. Journal of Pharmacology and Experimental Therapeutics. 327(3). 851–862. 51 indexed citations
8.
Bonneau, Olivier, et al.. (2005). Effect of adenosine A2Areceptor activation in murine models of respiratory disorders. American Journal of Physiology-Lung Cellular and Molecular Physiology. 290(5). L1036–L1043. 54 indexed citations
9.
Wyss, Daniel F., Ashok Arasappan, Mary M. Senior, et al.. (2004). Non-Peptidic Small-Molecule Inhibitors of the Single-Chain Hepatitis C Virus NS3 Protease/NS4A Cofactor Complex Discovered by Structure-Based NMR Screening. Journal of Medicinal Chemistry. 47(10). 2486–2498. 42 indexed citations
10.
Wang, Yu‐Sen, Dingjiang Liu, & Daniel F. Wyss. (2004). Competition STD NMR for the detection of high‐affinity ligands and NMR‐based screening. Magnetic Resonance in Chemistry. 42(6). 485–489. 110 indexed citations
11.
El‐Hashim, Ahmed Z., Daniel F. Wyss, & Christine A. Lewis. (2003). Effect of a novel NK1 receptor selective antagonist (NKP608) on citric acid induced cough and airway obstruction. Pulmonary Pharmacology & Therapeutics. 17(1). 11–18. 31 indexed citations
12.
Youngster, Stephen K., et al.. (2002). Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications. Advanced Drug Delivery Reviews. 54(4). 547–570. 313 indexed citations
13.
McCoy, Mark A. & Daniel F. Wyss. (2002). Spatial Localization of Ligand Binding Sites from Electron Current Density Surfaces Calculated from NMR Chemical Shift Perturbations. Journal of the American Chemical Society. 124(39). 11758–11763. 68 indexed citations
14.
Youngster, Stephen K., et al.. (2002). Structure, Biology, and Therapeutic Implications of Pegylated Interferon Alpha-2b. Current Pharmaceutical Design. 8(24). 2139–2157. 67 indexed citations
15.
Liu, Dingjiang, Yu‐Sen Wang, Jennifer J. Gesell, & Daniel F. Wyss. (2001). Solution structure and backbone dynamics of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA helicase 1 1Edited by M. F. Summers. Journal of Molecular Biology. 314(3). 543–561. 14 indexed citations
16.
McCrea, Jacqueline B., et al.. (1997). Pharmacokinetic interaction between indinavir and rifampin. Clinical Pharmacology & Therapeutics. 61(2). 152. 9 indexed citations
17.
Wyss, Daniel F. & Gerhard Wagner. (1996). The structural role of sugars in glycoproteins. Current Opinion in Biotechnology. 7(4). 409–416. 109 indexed citations
18.
Wagner, Gerhard & Daniel F. Wyss. (1994). Cell surface adhesion receptors. Current Opinion in Structural Biology. 4(6). 841–851. 22 indexed citations
19.
Wyss, Daniel F., et al.. (1993). Proton resonance assignments and secondary structure of the 13.6 kDa glycosylated adhesion domain of human CD2. Biochemistry. 32(41). 10995–11006. 29 indexed citations
20.
Withka, Jane M., Daniel F. Wyss, Gerhard Wagner, et al.. (1993). Structure of the glycosylated adhesion domain of human T lymphocyte glycoprotein CD2. Structure. 1(1). 69–81. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026